First Topical Therapy for Chronic Hand Eczema Wins FDA Approval

(MedPage Today) — The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.
The agency approved delgocitinib cream 2% (Anzupgo) for adults with moderate-to-severe CHE, according to a statement from LEO…